Merck & Co. (MRK)
(Delayed Data from NYSE)
$131.19 USD
+0.31 (0.24%)
Updated May 17, 2024 04:00 PM ET
After-Market: $131.20 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Price, Consensus and EPS Surprise
MRK 131.19 +0.31(0.24%)
Will MRK be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for MRK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MRK
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
5 Stocks Powering the Dow ETF Year to Date
MRK: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Merck (MRK) Crossed Above the 20-Day Moving Average: What That Means for Investors
The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E
Other News for MRK
Novo Nordisk, J&J lead R&D rankings in big pharma: report
10 Health Care Stocks Whale Activity In Today's Session
GLOBAL BROKER RATINGS: RBC cuts Inditex, Deutsche raises Roche
Dow at 40K: Leaders and laggards over the last 10,000 points
Storm Shelter: 7 Safe Haven Stocks to Batten Down the Hatches